Double Whammy!

3270

On the same day that the U.S. government was lamenting the news that obesity has caught up with smoking as a leading killer of Americans, a study demonstrated that a pill may help people quit smoking and lose weight at the same time.

Called rimonabant, the drug works by blocking certain receptors in the brain that urge people to smoke and eat. In research presented at the March 2004 American College of Cardiology Conference in New Orleans, rimonabant helped overweight people drop an average of 20 pounds in one study while doubling smokers’ success at quitting in another study.

Rimonabant developer Sanofi-Synthelabo of France financed the research. By next year, Sanofi-Synthelabo plans to seek U.S. approval to sell rimonabant under the brand name Acomplia.

Source: Daniel Q. Haney of the Associated Press, March 10, 2004

Click here to view/write comments
Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.